CA2580192A1 - Produit pharmaceutique comprenant des acides amines, des peptides, des proteines et/ou leurs fractions et fragments et son utilisation pour la prevention et le traitement de defauts du systeme immunitaire chez l'homme et chez les animaux - Google Patents

Info

Publication number

CA2580192A1

CA2580192A1 CA002580192A CA2580192A CA2580192A1 CA 2580192 A1 CA2580192 A1 CA 2580192A1 CA 002580192 A CA002580192 A CA 002580192A CA 2580192 A CA2580192 A CA 2580192A CA 2580192 A1 CA2580192 A1 CA 2580192A1

Authority

CA

Canada

Prior art keywords

protein

receptor

kinase

composition

cells

Prior art date

2004-09-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000011321 prophylaxis Methods 0.000 title claims abstract description 8
• 238000011282 treatment Methods 0.000 title claims description 28
• 239000000470 constituent Substances 0.000 title abstract description 4
• 230000007547 defect Effects 0.000 title abstract description 3
• 239000000825 pharmaceutical preparation Substances 0.000 title abstract description 3
• 229940127557 pharmaceutical product Drugs 0.000 title abstract description 3
• 239000008280 blood Substances 0.000 title description 16
• 210000004369 blood Anatomy 0.000 title description 15
• 210000000987 immune system Anatomy 0.000 title description 11
• 239000000203 mixture Substances 0.000 claims abstract description 104
• 238000002560 therapeutic procedure Methods 0.000 claims abstract description 27
• 206010040047 Sepsis Diseases 0.000 claims abstract description 18
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
• 241001465754 Metazoa Species 0.000 claims abstract description 14
• 238000004519 manufacturing process Methods 0.000 claims abstract description 13
• 230000001717 pathogenic effect Effects 0.000 claims abstract description 10
• 239000000824 cytostatic agent Substances 0.000 claims abstract description 9
• 230000004048 modification Effects 0.000 claims abstract description 8
• 238000012986 modification Methods 0.000 claims abstract description 8
• 230000007969 cellular immunity Effects 0.000 claims abstract description 7
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 7
• 238000001959 radiotherapy Methods 0.000 claims abstract description 6
• 238000002512 chemotherapy Methods 0.000 claims abstract description 5
• 238000000034 method Methods 0.000 claims description 46
• 239000000243 solution Substances 0.000 claims description 24
• 230000001413 cellular effect Effects 0.000 claims description 22
• 239000000047 product Substances 0.000 claims description 19
• 239000000306 component Substances 0.000 claims description 17
• 210000000265 leukocyte Anatomy 0.000 claims description 17
• 239000008177 pharmaceutical agent Substances 0.000 claims description 17
• 239000003814 drug Substances 0.000 claims description 15
• 235000018102 proteins Nutrition 0.000 claims description 15
• 239000003795 chemical substances by application Substances 0.000 claims description 14
• 238000004108 freeze drying Methods 0.000 claims description 14
• 239000000463 material Substances 0.000 claims description 13
• 208000013223 septicemia Diseases 0.000 claims description 13
• 102100033374 Leukotriene B4 receptor 1 Human genes 0.000 claims description 12
• 239000002243 precursor Substances 0.000 claims description 12
• 239000000126 substance Substances 0.000 claims description 12
• 229940079593 drug Drugs 0.000 claims description 11
• 239000000284 extract Substances 0.000 claims description 10
• -1 a-mannosidase Proteins 0.000 claims description 9
• 230000001954 sterilising effect Effects 0.000 claims description 9
• 238000004659 sterilization and disinfection Methods 0.000 claims description 9
• 102100023114 Dual specificity tyrosine-phosphorylation-regulated kinase 3 Human genes 0.000 claims description 8
• 101001049991 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 3 Proteins 0.000 claims description 8
• 101001017968 Homo sapiens Leukotriene B4 receptor 1 Proteins 0.000 claims description 8
• 102000004282 Ribosomal protein S9 Human genes 0.000 claims description 8
• 108090000878 Ribosomal protein S9 Proteins 0.000 claims description 8
• 239000002502 liposome Substances 0.000 claims description 8
• 238000009928 pasteurization Methods 0.000 claims description 8
• 239000000969 carrier Substances 0.000 claims description 7
• 239000012141 concentrate Substances 0.000 claims description 7
• 230000001419 dependent effect Effects 0.000 claims description 7
• 238000001802 infusion Methods 0.000 claims description 7
• 238000002347 injection Methods 0.000 claims description 7
• 239000007924 injection Substances 0.000 claims description 7
• 238000011045 prefiltration Methods 0.000 claims description 7
• 238000000108 ultra-filtration Methods 0.000 claims description 7
• 108010077544 Chromatin Proteins 0.000 claims description 6
• 108010006035 Metalloproteases Proteins 0.000 claims description 6
• 102000005741 Metalloproteases Human genes 0.000 claims description 6
• 102000001253 Protein Kinase Human genes 0.000 claims description 6
• 238000009739 binding Methods 0.000 claims description 6
• 230000027455 binding Effects 0.000 claims description 6
• 239000002775 capsule Substances 0.000 claims description 6
• 210000003483 chromatin Anatomy 0.000 claims description 6
• 108060006633 protein kinase Proteins 0.000 claims description 6
• 230000001105 regulatory effect Effects 0.000 claims description 6
• 102000004190 Enzymes Human genes 0.000 claims description 5
• 108090000790 Enzymes Proteins 0.000 claims description 5
• 206010061598 Immunodeficiency Diseases 0.000 claims description 5
• 208000029462 Immunodeficiency disease Diseases 0.000 claims description 5
• 239000012503 blood component Substances 0.000 claims description 5
• 229940088598 enzyme Drugs 0.000 claims description 5
• 238000000265 homogenisation Methods 0.000 claims description 5
• 230000007813 immunodeficiency Effects 0.000 claims description 5
• 239000002674 ointment Substances 0.000 claims description 5
• 102100034571 AT-rich interactive domain-containing protein 1B Human genes 0.000 claims description 4
• 102000007469 Actins Human genes 0.000 claims description 4
• 108010085238 Actins Proteins 0.000 claims description 4
• 102100032678 CapZ-interacting protein Human genes 0.000 claims description 4
• 102100025522 Cullin-7 Human genes 0.000 claims description 4
• 101710094593 Cullin-7 Proteins 0.000 claims description 4
• 102100031262 Deleted in malignant brain tumors 1 protein Human genes 0.000 claims description 4
• 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 claims description 4
• 102100023000 Glutamate-rich WD repeat-containing protein 1 Human genes 0.000 claims description 4
• 101000941906 Homo sapiens CapZ-interacting protein Proteins 0.000 claims description 4
• 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 claims description 4
• 101000903496 Homo sapiens Glutamate-rich WD repeat-containing protein 1 Proteins 0.000 claims description 4
• 101000782294 Homo sapiens Zinc finger protein 638 Proteins 0.000 claims description 4
• 101710123504 Ig heavy chain V region Proteins 0.000 claims description 4
• 102000000589 Interleukin-1 Human genes 0.000 claims description 4
• 108010002352 Interleukin-1 Proteins 0.000 claims description 4
• 108010028784 Interleukin-18 Receptor alpha Subunit Proteins 0.000 claims description 4
• 102000016919 Interleukin-18 Receptor alpha Subunit Human genes 0.000 claims description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
• 108090000093 Leukotriene B4 receptors Proteins 0.000 claims description 4
• 102100026299 MAP kinase-interacting serine/threonine-protein kinase 1 Human genes 0.000 claims description 4
• 101710139011 MAP kinase-interacting serine/threonine-protein kinase 1 Proteins 0.000 claims description 4
• 108091007877 MYCBP2 Proteins 0.000 claims description 4
• 102000006404 Mitochondrial Proteins Human genes 0.000 claims description 4
• 108010058682 Mitochondrial Proteins Proteins 0.000 claims description 4
• 108010008699 Mucin-4 Proteins 0.000 claims description 4
• 102000007270 Mucin-4 Human genes 0.000 claims description 4
• 102100023896 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D Human genes 0.000 claims description 4
• 101710180738 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D Proteins 0.000 claims description 4
• 102000011931 Nucleoproteins Human genes 0.000 claims description 4
• 108010061100 Nucleoproteins Proteins 0.000 claims description 4
• 108091000080 Phosphotransferase Proteins 0.000 claims description 4
• 102100036366 ProSAAS Human genes 0.000 claims description 4
• 101710095367 ProSAAS Proteins 0.000 claims description 4
• 102000001708 Protein Isoforms Human genes 0.000 claims description 4
• 108010029485 Protein Isoforms Proteins 0.000 claims description 4
• 102100034931 Protein mono-ADP-ribosyltransferase PARP4 Human genes 0.000 claims description 4
• 101710097451 Putative G-protein coupled receptor Proteins 0.000 claims description 4
• 102100039117 Putative vomeronasal receptor-like protein 4 Human genes 0.000 claims description 4
• 102000009609 Pyrophosphatases Human genes 0.000 claims description 4
• 108010009413 Pyrophosphatases Proteins 0.000 claims description 4
• 102300055050 Rho GTPase-activating protein 8 isoform 2 Human genes 0.000 claims description 4
• 102100020886 Sodium/iodide cotransporter Human genes 0.000 claims description 4
• 102000002938 Thrombospondin Human genes 0.000 claims description 4
• 108060008245 Thrombospondin Proteins 0.000 claims description 4
• 108010037150 Transient Receptor Potential Channels Proteins 0.000 claims description 4
• 102000011753 Transient Receptor Potential Channels Human genes 0.000 claims description 4
• 102100035806 Zinc finger protein 638 Human genes 0.000 claims description 4
• 230000007812 deficiency Effects 0.000 claims description 4
• 230000009977 dual effect Effects 0.000 claims description 4
• 210000002889 endothelial cell Anatomy 0.000 claims description 4
• 210000001365 lymphatic vessel Anatomy 0.000 claims description 4
• 239000011159 matrix material Substances 0.000 claims description 4
• 230000026731 phosphorylation Effects 0.000 claims description 4
• 238000006366 phosphorylation reaction Methods 0.000 claims description 4
• 102000020233 phosphotransferase Human genes 0.000 claims description 4
• 102000005962 receptors Human genes 0.000 claims description 4
• 108020003175 receptors Proteins 0.000 claims description 4
• 150000003839 salts Chemical class 0.000 claims description 4
• 108010013351 sodium-iodide symporter Proteins 0.000 claims description 4
• 238000007920 subcutaneous administration Methods 0.000 claims description 4
• 239000000758 substrate Substances 0.000 claims description 4
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
• 108010040963 vault poly(ADP-ribose) polymerase Proteins 0.000 claims description 4
• 102100027490 H2.0-like homeobox protein Human genes 0.000 claims description 3
• 101001081101 Homo sapiens H2.0-like homeobox protein Proteins 0.000 claims description 3
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims description 3
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims description 3
• 239000000872 buffer Substances 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• 239000000706 filtrate Substances 0.000 claims description 3
• 239000000314 lubricant Substances 0.000 claims description 3
• 229920001184 polypeptide Polymers 0.000 claims description 3
• 238000011146 sterile filtration Methods 0.000 claims description 3
• 235000000346 sugar Nutrition 0.000 claims description 3
• 239000000829 suppository Substances 0.000 claims description 3
• 238000009210 therapy by ultrasound Methods 0.000 claims description 3
• 229940088594 vitamin Drugs 0.000 claims description 3
• 239000011782 vitamin Substances 0.000 claims description 3
• 229930003231 vitamin Natural products 0.000 claims description 3
• 235000013343 vitamin Nutrition 0.000 claims description 3
• 239000000080 wetting agent Substances 0.000 claims description 3
• 102100021403 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial Human genes 0.000 claims description 2
• 102100027401 A disintegrin and metalloproteinase with thrombospondin motifs 3 Human genes 0.000 claims description 2
• 102000006267 AMP Deaminase Human genes 0.000 claims description 2
• 108700016228 AMP deaminases Proteins 0.000 claims description 2
• 108010049197 Axonemal Dyneins Proteins 0.000 claims description 2
• 102000009039 Axonemal Dyneins Human genes 0.000 claims description 2
• 102100025463 CD99 antigen-like protein 2 Human genes 0.000 claims description 2
• 102100021288 CUE domain-containing protein 1 Human genes 0.000 claims description 2
• 102000000905 Cadherin Human genes 0.000 claims description 2
• 108050007957 Cadherin Proteins 0.000 claims description 2
• 102100025332 Cadherin-9 Human genes 0.000 claims description 2
• 101710097558 Cadherin-9 Proteins 0.000 claims description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
• 102000000584 Calmodulin Human genes 0.000 claims description 2
• 108010041952 Calmodulin Proteins 0.000 claims description 2
• 102000005870 Coenzyme A Ligases Human genes 0.000 claims description 2
• 102100028257 Collagen alpha-1(XVI) chain Human genes 0.000 claims description 2
• 101710146163 Collagen alpha-1(XVI) chain Proteins 0.000 claims description 2
• 102000012437 Copper-Transporting ATPases Human genes 0.000 claims description 2
• 108010022637 Copper-Transporting ATPases Proteins 0.000 claims description 2
• 102100024354 Dedicator of cytokinesis protein 6 Human genes 0.000 claims description 2
• 101710088194 Dehydrogenase Proteins 0.000 claims description 2
• 102100030221 Diacylglycerol kinase theta Human genes 0.000 claims description 2
• 101710111480 Diacylglycerol kinase theta Proteins 0.000 claims description 2
• 102100031648 Dynein axonemal heavy chain 5 Human genes 0.000 claims description 2
• 102100023794 ETS domain-containing protein Elk-3 Human genes 0.000 claims description 2
• 239000004606 Fillers/Extenders Substances 0.000 claims description 2
• 108010075641 GATA2 Transcription Factor Proteins 0.000 claims description 2
• 102000011852 GATA2 Transcription Factor Human genes 0.000 claims description 2
• 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 claims description 2
• 101710117401 Glutathione reductase, mitochondrial Proteins 0.000 claims description 2
• 101001041661 Homo sapiens 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial Proteins 0.000 claims description 2
• 101000936403 Homo sapiens A disintegrin and metalloproteinase with thrombospondin motifs 2 Proteins 0.000 claims description 2
• 101000936395 Homo sapiens A disintegrin and metalloproteinase with thrombospondin motifs 3 Proteins 0.000 claims description 2
• 101100435491 Homo sapiens ARID1B gene Proteins 0.000 claims description 2
• 101000924255 Homo sapiens AT-rich interactive domain-containing protein 1B Proteins 0.000 claims description 2
• 101000984082 Homo sapiens CD99 antigen-like protein 2 Proteins 0.000 claims description 2
• 101000894809 Homo sapiens CUE domain-containing protein 1 Proteins 0.000 claims description 2
• 101001052950 Homo sapiens Dedicator of cytokinesis protein 6 Proteins 0.000 claims description 2
• 101000866368 Homo sapiens Dynein axonemal heavy chain 5 Proteins 0.000 claims description 2
• 101000664952 Homo sapiens E3 ubiquitin-protein ligase SMURF2 Proteins 0.000 claims description 2
• 101000970403 Homo sapiens Nuclear pore complex protein Nup153 Proteins 0.000 claims description 2
• 101000800639 Homo sapiens Teneurin-1 Proteins 0.000 claims description 2
• 101000829436 Homo sapiens Transcription elongation factor SPT6 Proteins 0.000 claims description 2
• 101000748141 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 32 Proteins 0.000 claims description 2
• 101000767597 Homo sapiens Vascular endothelial zinc finger 1 Proteins 0.000 claims description 2
• 101000964427 Homo sapiens Zinc finger and BTB domain-containing protein 14 Proteins 0.000 claims description 2
• 102000009433 Insulin Receptor Substrate Proteins Human genes 0.000 claims description 2
• 108010034219 Insulin Receptor Substrate Proteins Proteins 0.000 claims description 2
• 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 claims description 2
• 102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 claims description 2
• 101710178181 Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 claims description 2
• 241000713333 Mouse mammary tumor virus Species 0.000 claims description 2
• 101000964426 Mus musculus Zinc finger and BTB domain-containing protein 14 Proteins 0.000 claims description 2
• 108010094052 Nik related kinase Proteins 0.000 claims description 2
• 102100034340 Nik-related protein kinase Human genes 0.000 claims description 2
• 102100021706 Nuclear pore complex protein Nup153 Human genes 0.000 claims description 2
• 108090000854 Oxidoreductases Proteins 0.000 claims description 2
• 102000004316 Oxidoreductases Human genes 0.000 claims description 2
• 101710163348 Potassium voltage-gated channel subfamily H member 8 Proteins 0.000 claims description 2
• 102100031031 Probable global transcription activator SNF2L1 Human genes 0.000 claims description 2
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 claims description 2
• 102100029862 Sulfotransferase 1E1 Human genes 0.000 claims description 2
• 102100033213 Teneurin-1 Human genes 0.000 claims description 2
• 102100023690 Transcription elongation factor SPT6 Human genes 0.000 claims description 2
• 102100040050 Ubiquitin carboxyl-terminal hydrolase 32 Human genes 0.000 claims description 2
• 102000013814 Wnt Human genes 0.000 claims description 2
• 108050003627 Wnt Proteins 0.000 claims description 2
• 102100040315 Zinc finger and BTB domain-containing protein 14 Human genes 0.000 claims description 2
• 102100040812 Zinc finger protein 174 Human genes 0.000 claims description 2
• 101710145405 Zinc finger protein 174 Proteins 0.000 claims description 2
• 239000003463 adsorbent Substances 0.000 claims description 2
• 239000011230 binding agent Substances 0.000 claims description 2
• 229910052791 calcium Inorganic materials 0.000 claims description 2
• 239000011575 calcium Substances 0.000 claims description 2
• 230000008859 change Effects 0.000 claims description 2
• 108090000999 claudin 10 Proteins 0.000 claims description 2
• 102000004361 claudin 10 Human genes 0.000 claims description 2
• 239000006071 cream Substances 0.000 claims description 2
• 239000007884 disintegrant Substances 0.000 claims description 2
• 238000004090 dissolution Methods 0.000 claims description 2
• 239000003623 enhancer Substances 0.000 claims description 2
• 108010017360 estrone sulfotransferase Proteins 0.000 claims description 2
• 239000000945 filler Substances 0.000 claims description 2
• 239000003906 humectant Substances 0.000 claims description 2
• 230000010354 integration Effects 0.000 claims description 2
• 238000007918 intramuscular administration Methods 0.000 claims description 2
• 238000007912 intraperitoneal administration Methods 0.000 claims description 2
• 238000001990 intravenous administration Methods 0.000 claims description 2
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 claims description 2
• 235000013311 vegetables Nutrition 0.000 claims description 2
• 229960004441 tyrosine Drugs 0.000 claims 2
• 235000002374 tyrosine Nutrition 0.000 claims 2
• 101000702560 Homo sapiens Probable global transcription activator SNF2L1 Proteins 0.000 claims 1
• 102100029663 Mediator of RNA polymerase II transcription subunit 15 Human genes 0.000 claims 1
• 101710179287 Mediator of RNA polymerase II transcription subunit 15 Proteins 0.000 claims 1
• 102000004885 Protease-activated receptor 4 Human genes 0.000 claims 1
• 108090001010 Protease-activated receptor 4 Proteins 0.000 claims 1
• 102000015176 Proton-Translocating ATPases Human genes 0.000 claims 1
• 108010039518 Proton-Translocating ATPases Proteins 0.000 claims 1
• 239000006260 foam Substances 0.000 claims 1
• 239000002353 niosome Substances 0.000 claims 1
• 229940070376 protein Drugs 0.000 claims 1
• 239000000941 radioactive substance Substances 0.000 claims 1
• 239000006215 rectal suppository Substances 0.000 claims 1
• 229940100618 rectal suppository Drugs 0.000 claims 1
• 238000001179 sorption measurement Methods 0.000 claims 1
• 230000000699 topical effect Effects 0.000 claims 1
• 239000006216 vaginal suppository Substances 0.000 claims 1
• 229940120293 vaginal suppository Drugs 0.000 claims 1
• 206010028980 Neoplasm Diseases 0.000 abstract description 61
• 201000011510 cancer Diseases 0.000 abstract description 19
• 206010020751 Hypersensitivity Diseases 0.000 abstract description 6
• 230000001085 cytostatic effect Effects 0.000 abstract 1
• 210000004027 cell Anatomy 0.000 description 42
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 39
• 201000010099 disease Diseases 0.000 description 31
• 239000013543 active substance Substances 0.000 description 20
• 230000000694 effects Effects 0.000 description 14
• 238000006243 chemical reaction Methods 0.000 description 13
• 230000008569 process Effects 0.000 description 13
• 230000000069 prophylactic effect Effects 0.000 description 12
• 230000001225 therapeutic effect Effects 0.000 description 12
• 201000009030 Carcinoma Diseases 0.000 description 11
• 150000001875 compounds Chemical class 0.000 description 11
• 238000009472 formulation Methods 0.000 description 11
• 230000001965 increasing effect Effects 0.000 description 11
• 239000003826 tablet Substances 0.000 description 11
• 238000012360 testing method Methods 0.000 description 11
• 230000006872 improvement Effects 0.000 description 10
• 210000004379 membrane Anatomy 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 230000024932 T cell mediated immunity Effects 0.000 description 9
• 210000001744 T-lymphocyte Anatomy 0.000 description 9
• 244000309466 calf Species 0.000 description 9
• 230000006378 damage Effects 0.000 description 9
• 238000000502 dialysis Methods 0.000 description 9
• 230000004054 inflammatory process Effects 0.000 description 9
• 210000000056 organ Anatomy 0.000 description 9
• 208000023275 Autoimmune disease Diseases 0.000 description 8
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
• 206010061218 Inflammation Diseases 0.000 description 8
• 230000015572 biosynthetic process Effects 0.000 description 8
• 208000035475 disorder Diseases 0.000 description 8
• 235000019441 ethanol Nutrition 0.000 description 8
• 239000002904 solvent Substances 0.000 description 8
• 239000007858 starting material Substances 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 208000032839 leukemia Diseases 0.000 description 7
• 210000001519 tissue Anatomy 0.000 description 7
• 210000004881 tumor cell Anatomy 0.000 description 7
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
• 206010027476 Metastases Diseases 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 230000037396 body weight Effects 0.000 description 6
• 238000002648 combination therapy Methods 0.000 description 6
• 238000001914 filtration Methods 0.000 description 6
• 238000007710 freezing Methods 0.000 description 6
• 230000008014 freezing Effects 0.000 description 6
• 230000001976 improved effect Effects 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 239000008194 pharmaceutical composition Substances 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 208000011580 syndromic disease Diseases 0.000 description 6
• 208000017604 Hodgkin disease Diseases 0.000 description 5
• 201000004681 Psoriasis Diseases 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 210000000601 blood cell Anatomy 0.000 description 5
• 208000003362 bronchogenic carcinoma Diseases 0.000 description 5
• 210000003169 central nervous system Anatomy 0.000 description 5
• 235000008504 concentrate Nutrition 0.000 description 5
• 230000036425 denaturation Effects 0.000 description 5
• 238000004925 denaturation Methods 0.000 description 5
• 239000006196 drop Substances 0.000 description 5
• 210000003743 erythrocyte Anatomy 0.000 description 5
• 210000004698 lymphocyte Anatomy 0.000 description 5
• 239000002245 particle Substances 0.000 description 5
• 244000052769 pathogen Species 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 210000002307 prostate Anatomy 0.000 description 5
• 230000005855 radiation Effects 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
• 208000030507 AIDS Diseases 0.000 description 4
• 206010009944 Colon cancer Diseases 0.000 description 4
• 206010025323 Lymphomas Diseases 0.000 description 4
• 206010037660 Pyrexia Diseases 0.000 description 4
• 206010039491 Sarcoma Diseases 0.000 description 4
• 208000027418 Wounds and injury Diseases 0.000 description 4
• 208000010668 atopic eczema Diseases 0.000 description 4
• 210000001185 bone marrow Anatomy 0.000 description 4
• 239000012050 conventional carrier Substances 0.000 description 4
• 210000004443 dendritic cell Anatomy 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 239000000839 emulsion Substances 0.000 description 4
• 239000012634 fragment Substances 0.000 description 4
• 230000001900 immune effect Effects 0.000 description 4
• 208000014674 injury Diseases 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 210000003734 kidney Anatomy 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 230000036210 malignancy Effects 0.000 description 4
• 230000004060 metabolic process Effects 0.000 description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 description 4
• 230000001575 pathological effect Effects 0.000 description 4
• 238000010257 thawing Methods 0.000 description 4
• 201000004384 Alopecia Diseases 0.000 description 3
• 206010006417 Bronchial carcinoma Diseases 0.000 description 3
• 241000700198 Cavia Species 0.000 description 3
• 102000004127 Cytokines Human genes 0.000 description 3
• 108090000695 Cytokines Proteins 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 208000006168 Ewing Sarcoma Diseases 0.000 description 3
• 206010016654 Fibrosis Diseases 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
• 206010027406 Mesothelioma Diseases 0.000 description 3
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
• 206010029260 Neuroblastoma Diseases 0.000 description 3
• 201000009053 Neurodermatitis Diseases 0.000 description 3
• 208000009905 Neurofibromatoses Diseases 0.000 description 3
• 208000002193 Pain Diseases 0.000 description 3
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 3
• 206010060862 Prostate cancer Diseases 0.000 description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• 208000009956 adenocarcinoma Diseases 0.000 description 3
• 230000007815 allergy Effects 0.000 description 3
• 230000001363 autoimmune Effects 0.000 description 3
• 230000017531 blood circulation Effects 0.000 description 3
• 210000000481 breast Anatomy 0.000 description 3
• 239000012876 carrier material Substances 0.000 description 3
• 230000001684 chronic effect Effects 0.000 description 3
• 208000019425 cirrhosis of liver Diseases 0.000 description 3
• 210000001072 colon Anatomy 0.000 description 3
• 206010012601 diabetes mellitus Diseases 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 230000007613 environmental effect Effects 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 239000000499 gel Substances 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 210000003714 granulocyte Anatomy 0.000 description 3
• 229960001340 histamine Drugs 0.000 description 3
• 230000007062 hydrolysis Effects 0.000 description 3
• 238000006460 hydrolysis reaction Methods 0.000 description 3
• 230000008105 immune reaction Effects 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 238000009169 immunotherapy Methods 0.000 description 3
• 230000002757 inflammatory effect Effects 0.000 description 3
• 229940090044 injection Drugs 0.000 description 3
• 230000009545 invasion Effects 0.000 description 3
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 201000005202 lung cancer Diseases 0.000 description 3
• 208000020816 lung neoplasm Diseases 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 244000005700 microbiome Species 0.000 description 3
• 210000001616 monocyte Anatomy 0.000 description 3
• 201000004931 neurofibromatosis Diseases 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 210000000496 pancreas Anatomy 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 235000004252 protein component Nutrition 0.000 description 3
• 206010039073 rheumatoid arthritis Diseases 0.000 description 3
• 239000007921 spray Substances 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 230000008093 supporting effect Effects 0.000 description 3
• 239000000375 suspending agent Substances 0.000 description 3
• 239000007939 sustained release tablet Substances 0.000 description 3
• 210000001550 testis Anatomy 0.000 description 3
• 231100000331 toxic Toxicity 0.000 description 3
• 230000002588 toxic effect Effects 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
• 208000002008 AIDS-Related Lymphoma Diseases 0.000 description 2
• 208000026872 Addison Disease Diseases 0.000 description 2
• 206010001233 Adenoma benign Diseases 0.000 description 2
• 201000003076 Angiosarcoma Diseases 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 101800004538 Bradykinin Proteins 0.000 description 2
• 208000007333 Brain Concussion Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 206010007270 Carcinoid syndrome Diseases 0.000 description 2
• 229920002261 Corn starch Polymers 0.000 description 2
• 208000011231 Crohn disease Diseases 0.000 description 2
• 201000003883 Cystic fibrosis Diseases 0.000 description 2
• 201000004624 Dermatitis Diseases 0.000 description 2
• 206010012438 Dermatitis atopic Diseases 0.000 description 2
• 201000003066 Diffuse Scleroderma Diseases 0.000 description 2
• QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 2
• 208000001204 Hashimoto Disease Diseases 0.000 description 2
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 2
• 208000001258 Hemangiosarcoma Diseases 0.000 description 2
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 2
• 208000031220 Hemophilia Diseases 0.000 description 2
• 208000009292 Hemophilia A Diseases 0.000 description 2
• 206010020850 Hyperthyroidism Diseases 0.000 description 2
• 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 2
• 206010062016 Immunosuppression Diseases 0.000 description 2
• 206010061216 Infarction Diseases 0.000 description 2
• 206010022941 Iridocyclitis Diseases 0.000 description 2
• 208000007766 Kaposi sarcoma Diseases 0.000 description 2
• 102100035792 Kininogen-1 Human genes 0.000 description 2
• 206010027457 Metastases to liver Diseases 0.000 description 2
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
• 208000005927 Myosarcoma Diseases 0.000 description 2
• 206010028665 Myxoedema Diseases 0.000 description 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
• 229930012538 Paclitaxel Natural products 0.000 description 2
• 108090000526 Papain Proteins 0.000 description 2
• 201000011152 Pemphigus Diseases 0.000 description 2
• 208000031845 Pernicious anaemia Diseases 0.000 description 2
• 208000007452 Plasmacytoma Diseases 0.000 description 2
• 208000000474 Poliomyelitis Diseases 0.000 description 2
• 206010036030 Polyarthritis Diseases 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 208000021386 Sjogren Syndrome Diseases 0.000 description 2
• 208000000453 Skin Neoplasms Diseases 0.000 description 2
• 206010054184 Small intestine carcinoma Diseases 0.000 description 2
• 206010042742 Sympathetic ophthalmia Diseases 0.000 description 2
• 201000009594 Systemic Scleroderma Diseases 0.000 description 2
• 208000018359 Systemic autoimmune disease Diseases 0.000 description 2
• 206010042953 Systemic sclerosis Diseases 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
• 208000002495 Uterine Neoplasms Diseases 0.000 description 2
• XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 238000011166 aliquoting Methods 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 201000004612 anterior uveitis Diseases 0.000 description 2
• 239000007900 aqueous suspension Substances 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 201000008937 atopic dermatitis Diseases 0.000 description 2
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 2
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 2
• 229960002170 azathioprine Drugs 0.000 description 2
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 2
• 235000012216 bentonite Nutrition 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 210000004204 blood vessel Anatomy 0.000 description 2
• 206010006007 bone sarcoma Diseases 0.000 description 2
• QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 2
• 201000008275 breast carcinoma Diseases 0.000 description 2
• 235000019437 butane-1,3-diol Nutrition 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 239000004359 castor oil Substances 0.000 description 2
• 235000019438 castor oil Nutrition 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 230000002490 cerebral effect Effects 0.000 description 2
• 230000000973 chemotherapeutic effect Effects 0.000 description 2
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 2
• 230000004087 circulation Effects 0.000 description 2
• 230000007882 cirrhosis Effects 0.000 description 2
• 238000004140 cleaning Methods 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 239000003086 colorant Substances 0.000 description 2
• 239000008120 corn starch Substances 0.000 description 2
• 230000007123 defense Effects 0.000 description 2
• 201000001981 dermatomyositis Diseases 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 239000003651 drinking water Substances 0.000 description 2
• 235000020188 drinking water Nutrition 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 229940120655 eloxatin Drugs 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 2
• 239000003925 fat Substances 0.000 description 2
• 235000019197 fats Nutrition 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• 238000011049 filling Methods 0.000 description 2
• 230000037406 food intake Effects 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 208000010749 gastric carcinoma Diseases 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
• 230000003676 hair loss Effects 0.000 description 2
• 230000004727 humoral immunity Effects 0.000 description 2
• 230000007124 immune defense Effects 0.000 description 2
• 230000003308 immunostimulating effect Effects 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 230000007574 infarction Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 239000007972 injectable composition Substances 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 238000004255 ion exchange chromatography Methods 0.000 description 2
• 210000003292 kidney cell Anatomy 0.000 description 2
• 230000003902 lesion Effects 0.000 description 2
• 206010024378 leukocytosis Diseases 0.000 description 2
• 201000002364 leukopenia Diseases 0.000 description 2
• 231100001022 leukopenia Toxicity 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 206010025135 lupus erythematosus Diseases 0.000 description 2
• 208000012804 lymphangiosarcoma Diseases 0.000 description 2
• 239000003287 lymphocyte surface marker Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 210000001370 mediastinum Anatomy 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 201000002077 muscle cancer Diseases 0.000 description 2
• 208000003786 myxedema Diseases 0.000 description 2
• 208000001611 myxosarcoma Diseases 0.000 description 2
• 239000000346 nonvolatile oil Substances 0.000 description 2
• 239000004006 olive oil Substances 0.000 description 2
• 235000008390 olive oil Nutrition 0.000 description 2
• 229960001592 paclitaxel Drugs 0.000 description 2
• 230000036407 pain Effects 0.000 description 2
• 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 2
• 229940055729 papain Drugs 0.000 description 2
• 235000019834 papain Nutrition 0.000 description 2
• 208000003154 papilloma Diseases 0.000 description 2
• 208000007312 paraganglioma Diseases 0.000 description 2
• 208000012111 paraneoplastic syndrome Diseases 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 201000001976 pemphigus vulgaris Diseases 0.000 description 2
• 208000010918 peritoneal neoplasm Diseases 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 208000010626 plasma cell neoplasm Diseases 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 229960004063 propylene glycol Drugs 0.000 description 2
• 238000003908 quality control method Methods 0.000 description 2
• 208000020615 rectal carcinoma Diseases 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
• 238000004062 sedimentation Methods 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
• 235000012239 silicon dioxide Nutrition 0.000 description 2
• 201000000498 stomach carcinoma Diseases 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
• 210000001685 thyroid gland Anatomy 0.000 description 2
• 208000005057 thyrotoxicosis Diseases 0.000 description 2
• 239000000196 tragacanth Substances 0.000 description 2
• 235000010487 tragacanth Nutrition 0.000 description 2
• 229940116362 tragacanth Drugs 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 210000003932 urinary bladder Anatomy 0.000 description 2
• 206010046766 uterine cancer Diseases 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• 229940058015 1,3-butylene glycol Drugs 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 208000010400 APUDoma Diseases 0.000 description 1
• 206010000369 Accident Diseases 0.000 description 1
• 208000002874 Acne Vulgaris Diseases 0.000 description 1
• 208000007876 Acrospiroma Diseases 0.000 description 1
• 206010000830 Acute leukaemia Diseases 0.000 description 1
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
• 206010048998 Acute phase reaction Diseases 0.000 description 1
• 208000000583 Adenolymphoma Diseases 0.000 description 1
• 208000003200 Adenoma Diseases 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 201000010000 Agranulocytosis Diseases 0.000 description 1
• 206010001580 Albuminuria Diseases 0.000 description 1
• 206010053164 Alcohol withdrawal syndrome Diseases 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 206010002383 Angina Pectoris Diseases 0.000 description 1
• 208000005034 Angiolymphoid Hyperplasia with Eosinophilia Diseases 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
• 206010060983 Apical granuloma Diseases 0.000 description 1
• 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 206010003226 Arteriovenous fistula Diseases 0.000 description 1
• 208000004736 B-Cell Leukemia Diseases 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
• 102000051618 BRCA1-associated protein Human genes 0.000 description 1
• 101710196510 BRCA1-associated protein Proteins 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 231100000699 Bacterial toxin Toxicity 0.000 description 1
• 206010004146 Basal cell carcinoma Diseases 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 201000006935 Becker muscular dystrophy Diseases 0.000 description 1
• 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
• 208000035821 Benign schwannoma Diseases 0.000 description 1
• 208000003609 Bile Duct Adenoma Diseases 0.000 description 1
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
• 208000035462 Biphenotypic Acute Leukemia Diseases 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 208000000529 Branchioma Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 206010058354 Bronchioloalveolar carcinoma Diseases 0.000 description 1
• 208000002908 Brown-Pearce carcinoma Diseases 0.000 description 1
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
• 201000000274 Carcinosarcoma Diseases 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 206010007882 Cellulitis Diseases 0.000 description 1
• 208000007389 Cementoma Diseases 0.000 description 1
• 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
• 208000007190 Chlamydia Infections Diseases 0.000 description 1
• 206010008642 Cholesteatoma Diseases 0.000 description 1
• 201000005262 Chondroma Diseases 0.000 description 1
• 208000005243 Chondrosarcoma Diseases 0.000 description 1
• 201000009047 Chordoma Diseases 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 208000016216 Choristoma Diseases 0.000 description 1
• 208000000094 Chronic Pain Diseases 0.000 description 1
• 208000035865 Chronic mast cell leukemia Diseases 0.000 description 1
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 206010010254 Concussion Diseases 0.000 description 1
• 208000034657 Convalescence Diseases 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
• 208000014997 Crohn colitis Diseases 0.000 description 1
• 201000005171 Cystadenoma Diseases 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 206010012442 Dermatitis contact Diseases 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 101100285419 Drosophila melanogaster H2.0 gene Proteins 0.000 description 1
• 206010013786 Dry skin Diseases 0.000 description 1
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
• 208000006402 Ductal Carcinoma Diseases 0.000 description 1
• 208000007033 Dysgerminoma Diseases 0.000 description 1
• 206010058314 Dysplasia Diseases 0.000 description 1
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
• 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 208000010228 Erectile Dysfunction Diseases 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 208000005163 Extra-Adrenal Paraganglioma Diseases 0.000 description 1
• 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 206010053717 Fibrous histiocytoma Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 208000007882 Gastritis Diseases 0.000 description 1
• 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
• 208000007569 Giant Cell Tumors Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 201000005618 Glomus Tumor Diseases 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 208000024869 Goodpasture syndrome Diseases 0.000 description 1
• 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 1
• 208000005234 Granulosa Cell Tumor Diseases 0.000 description 1
• 206010018910 Haemolysis Diseases 0.000 description 1
• 208000002927 Hamartoma Diseases 0.000 description 1
• 206010019196 Head injury Diseases 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 208000002125 Hemangioendothelioma Diseases 0.000 description 1
• 208000006050 Hemangiopericytoma Diseases 0.000 description 1
• 206010019468 Hemiplegia Diseases 0.000 description 1
• 208000007514 Herpes zoster Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 208000002291 Histiocytic Sarcoma Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000651439 Homo sapiens Prothrombin Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 206010062767 Hypophysitis Diseases 0.000 description 1
• 238000012369 In process control Methods 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 206010061252 Intraocular melanoma Diseases 0.000 description 1
• 208000009164 Islet Cell Adenoma Diseases 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 208000018142 Leiomyosarcoma Diseases 0.000 description 1
• 208000034624 Leukocytoclastic Cutaneous Vasculitis Diseases 0.000 description 1
• 208000032514 Leukocytoclastic vasculitis Diseases 0.000 description 1
• 201000004462 Leydig Cell Tumor Diseases 0.000 description 1
• 206010024612 Lipoma Diseases 0.000 description 1
• 206010024769 Local reaction Diseases 0.000 description 1
• 206010025219 Lymphangioma Diseases 0.000 description 1
• 208000004138 Lymphangiomyoma Diseases 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
• 241000213879 Lyssa Species 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 206010025421 Macule Diseases 0.000 description 1
• 208000008095 Malignant Carcinoid Syndrome Diseases 0.000 description 1
• 206010025538 Malignant ascites Diseases 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 206010027260 Meningitis viral Diseases 0.000 description 1
• 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
• 208000010153 Mesonephroma Diseases 0.000 description 1
• 206010027452 Metastases to bone Diseases 0.000 description 1
• 206010059282 Metastases to central nervous system Diseases 0.000 description 1
• 206010027458 Metastases to lung Diseases 0.000 description 1
• 206010051676 Metastases to peritoneum Diseases 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 208000007727 Muscle Tissue Neoplasms Diseases 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• 201000004458 Myoma Diseases 0.000 description 1
• 206010028851 Necrosis Diseases 0.000 description 1
• 206010029098 Neoplasm skin Diseases 0.000 description 1
• 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
• 101710151472 Neuroendocrine convertase 1 Proteins 0.000 description 1
• 102100032132 Neuroendocrine convertase 1 Human genes 0.000 description 1
• 201000004404 Neurofibroma Diseases 0.000 description 1
• 208000005890 Neuroma Diseases 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• 206010030302 Oliguria Diseases 0.000 description 1
• 208000009095 Orbital Neoplasms Diseases 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 206010033078 Otitis media Diseases 0.000 description 1
• 206010061332 Paraganglion neoplasm Diseases 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 208000037273 Pathologic Processes Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 206010049592 Peritonsillitis Diseases 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 208000002163 Phyllodes Tumor Diseases 0.000 description 1
• 206010071776 Phyllodes tumour Diseases 0.000 description 1
• 208000007641 Pinealoma Diseases 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 208000033014 Plasma cell tumor Diseases 0.000 description 1
• 208000013544 Platelet disease Diseases 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 206010036105 Polyneuropathy Diseases 0.000 description 1
• 208000037062 Polyps Diseases 0.000 description 1
• 206010036205 Portal vein phlebitis Diseases 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• 208000033759 Prolymphocytic T-Cell Leukemia Diseases 0.000 description 1
• 102100027378 Prothrombin Human genes 0.000 description 1
• 206010037294 Puerperal pyrexia Diseases 0.000 description 1
• 206010037423 Pulmonary oedema Diseases 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 208000034541 Rare lymphatic malformation Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
• 206010038802 Reticuloendothelial system stimulated Diseases 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• 208000005678 Rhabdomyoma Diseases 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 208000034189 Sclerosis Diseases 0.000 description 1
• 208000003274 Sertoli cell tumor Diseases 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 206010068771 Soft tissue neoplasm Diseases 0.000 description 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 208000006011 Stroke Diseases 0.000 description 1
• 206010042658 Sweat gland tumour Diseases 0.000 description 1
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 description 1
• 208000001871 Tachycardia Diseases 0.000 description 1
• 206010043276 Teratoma Diseases 0.000 description 1
• 244000299461 Theobroma cacao Species 0.000 description 1
• 235000009470 Theobroma cacao Nutrition 0.000 description 1
• 206010053615 Thermal burn Diseases 0.000 description 1
• 206010043945 Tongue coated Diseases 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 206010045171 Tumour pain Diseases 0.000 description 1
• 208000010097 Unknown Primary Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 201000005969 Uveal melanoma Diseases 0.000 description 1
• 206010046851 Uveitis Diseases 0.000 description 1
• 201000003761 Vaginal carcinoma Diseases 0.000 description 1
• 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
• 208000021146 Warthin tumor Diseases 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
• NARKTLKJPPMFJF-LEJQEAHTSA-N [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl n-[(2s)-2,6-diaminohexanoyl]sulfamate Chemical compound O[C@@H]1[C@H](O)[C@@H](COS(=O)(=O)NC(=O)[C@@H](N)CCCCN)O[C@H]1N1C2=NC=NC(N)=C2N=C1 NARKTLKJPPMFJF-LEJQEAHTSA-N 0.000 description 1
• 210000000683 abdominal cavity Anatomy 0.000 description 1
• 206010000269 abscess Diseases 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 206010000496 acne Diseases 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 201000004471 adenofibroma Diseases 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 208000018234 adnexal spiradenoma/cylindroma of a sweat gland Diseases 0.000 description 1
• 210000004404 adrenal cortex Anatomy 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 208000029650 alcohol withdrawal Diseases 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 230000001618 algogenic effect Effects 0.000 description 1
• 239000012670 alkaline solution Substances 0.000 description 1
• 231100000360 alopecia Toxicity 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 235000010210 aluminium Nutrition 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 208000010029 ameloblastoma Diseases 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 201000007538 anal carcinoma Diseases 0.000 description 1
• 201000009431 angiokeratoma Diseases 0.000 description 1
• 208000000252 angiomatosis Diseases 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 208000021328 arterial occlusion Diseases 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• 239000012752 auxiliary agent Substances 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 239000013570 bacterial allergen Substances 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 239000000688 bacterial toxin Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 208000021592 benign granular cell tumor Diseases 0.000 description 1
• 239000000440 bentonite Substances 0.000 description 1
• 229910000278 bentonite Inorganic materials 0.000 description 1
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 210000003445 biliary tract Anatomy 0.000 description 1
• 201000001531 bladder carcinoma Diseases 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 210000001772 blood platelet Anatomy 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 239000002639 bone cement Substances 0.000 description 1
• 201000006491 bone marrow cancer Diseases 0.000 description 1
• 239000000337 buffer salt Substances 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 239000008364 bulk solution Substances 0.000 description 1
• 235000001465 calcium Nutrition 0.000 description 1
• 229960005069 calcium Drugs 0.000 description 1
• 229910001424 calcium ion Inorganic materials 0.000 description 1
• 239000000378 calcium silicate Substances 0.000 description 1
• 229910052918 calcium silicate Inorganic materials 0.000 description 1
• OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
• 230000035571 calor Effects 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 208000005761 carcinoid heart disease Diseases 0.000 description 1
• 208000025106 carcinoma of duodenum Diseases 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000001364 causal effect Effects 0.000 description 1
• 230000025084 cell cycle arrest Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000002032 cellular defenses Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 235000010980 cellulose Nutrition 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 208000025997 central nervous system neoplasm Diseases 0.000 description 1
• 229930183167 cerebroside Natural products 0.000 description 1
• 150000001784 cerebrosides Chemical class 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 208000019065 cervical carcinoma Diseases 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 230000035605 chemotaxis Effects 0.000 description 1
• 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
• 208000003167 cholangitis Diseases 0.000 description 1
• 201000001352 cholecystitis Diseases 0.000 description 1
• 201000005217 chondroblastoma Diseases 0.000 description 1
• 208000023652 chronic gastritis Diseases 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000009060 clear cell adenocarcinoma Diseases 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 230000007012 clinical effect Effects 0.000 description 1
• 206010009887 colitis Diseases 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000002301 combined effect Effects 0.000 description 1
• 230000004154 complement system Effects 0.000 description 1
• 150000004695 complexes Chemical class 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 208000010247 contact dermatitis Diseases 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 208000018261 cutaneous leukocytoclastic angiitis Diseases 0.000 description 1
• 208000030381 cutaneous melanoma Diseases 0.000 description 1
• 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 208000002445 cystadenocarcinoma Diseases 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 230000000254 damaging effect Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 201000010064 diabetes insipidus Diseases 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 210000002249 digestive system Anatomy 0.000 description 1
• 230000010339 dilation Effects 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 230000035620 dolor Effects 0.000 description 1
• 239000003221 ear drop Substances 0.000 description 1
• 229940047652 ear drops Drugs 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000000909 electrodialysis Methods 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 230000002996 emotional effect Effects 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 210000000750 endocrine system Anatomy 0.000 description 1
• 208000030172 endocrine system disease Diseases 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 230000001834 epinephrinelike Effects 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 239000010642 eucalyptus oil Substances 0.000 description 1
• 229940044949 eucalyptus oil Drugs 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 239000003885 eye ointment Substances 0.000 description 1
• 206010016256 fatigue Diseases 0.000 description 1
• 150000002194 fatty esters Chemical class 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 206010016629 fibroma Diseases 0.000 description 1
• 201000008825 fibrosarcoma of bone Diseases 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
• ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 201000008361 ganglioneuroma Diseases 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 201000005626 glomangioma Diseases 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 229940074076 glycerol formal Drugs 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 201000011066 hemangioma Diseases 0.000 description 1
• 230000008588 hemolysis Effects 0.000 description 1
• 208000007475 hemolytic anemia Diseases 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 201000005133 hidradenoma Diseases 0.000 description 1
• 201000009379 histiocytoid hemangioma Diseases 0.000 description 1
• 201000000284 histiocytoma Diseases 0.000 description 1
• 239000012510 hollow fiber Substances 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 210000003026 hypopharynx Anatomy 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000008629 immune suppression Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000006058 immune tolerance Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 201000001881 impotence Diseases 0.000 description 1
• 201000004933 in situ carcinoma Diseases 0.000 description 1
• 238000010965 in-process control Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 208000021267 infertility disease Diseases 0.000 description 1
• 239000005550 inflammation mediator Substances 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 229940102213 injectable suspension Drugs 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 201000008267 intestinal tuberculosis Diseases 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 230000035987 intoxication Effects 0.000 description 1
• 231100000566 intoxication Toxicity 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 230000005865 ionizing radiation Effects 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 201000002529 islet cell tumor Diseases 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 229960004592 isopropanol Drugs 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 150000002605 large molecules Chemical class 0.000 description 1
• 210000000867 larynx Anatomy 0.000 description 1
• 201000010260 leiomyoma Diseases 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 210000000088 lip Anatomy 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 201000000966 lung oat cell carcinoma Diseases 0.000 description 1
• 201000010453 lymph node cancer Diseases 0.000 description 1
• 206010025226 lymphangitis Diseases 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229940057948 magnesium stearate Drugs 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 201000006812 malignant histiocytosis Diseases 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 201000008749 mast-cell sarcoma Diseases 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 238000011034 membrane dialysis Methods 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 230000009245 menopause Effects 0.000 description 1
• 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
• 208000004197 mesenchymoma Diseases 0.000 description 1
• 208000011831 mesonephric neoplasm Diseases 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 238000001471 micro-filtration Methods 0.000 description 1
• 230000003641 microbiacidal effect Effects 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 206010051747 multiple endocrine neoplasia Diseases 0.000 description 1
• 230000003387 muscular Effects 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 201000004130 myoblastoma Diseases 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• 230000002956 necrotizing effect Effects 0.000 description 1
• 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 201000008026 nephroblastoma Diseases 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 230000001379 nervous effect Effects 0.000 description 1
• 208000007538 neurilemmoma Diseases 0.000 description 1
• 208000029986 neuroepithelioma Diseases 0.000 description 1
• 208000014500 neuronal tumor Diseases 0.000 description 1
• 230000003448 neutrophilic effect Effects 0.000 description 1
• 239000012299 nitrogen atmosphere Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 210000001331 nose Anatomy 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 201000005508 null-cell leukemia Diseases 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 201000002575 ocular melanoma Diseases 0.000 description 1
• 208000004128 odontoma Diseases 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 206010030306 omphalitis Diseases 0.000 description 1
• 208000025303 orbit neoplasm Diseases 0.000 description 1
• 210000004789 organ system Anatomy 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 210000003300 oropharynx Anatomy 0.000 description 1
• 208000008798 osteoma Diseases 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 210000003101 oviduct Anatomy 0.000 description 1
• 230000004783 oxidative metabolism Effects 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 208000021090 palsy Diseases 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000017909 pancreatic neuroendocrine tumor G1 Diseases 0.000 description 1
• 201000010198 papillary carcinoma Diseases 0.000 description 1
• 210000003695 paranasal sinus Anatomy 0.000 description 1
• 230000000849 parathyroid Effects 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 230000009054 pathological process Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 210000004197 pelvis Anatomy 0.000 description 1
• 210000003899 penis Anatomy 0.000 description 1
• 235000019477 peppermint oil Nutrition 0.000 description 1
• 201000009021 periapical granuloma Diseases 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000004303 peritoneum Anatomy 0.000 description 1
• 210000001539 phagocyte Anatomy 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 208000024724 pineal body neoplasm Diseases 0.000 description 1
• 201000004123 pineal gland cancer Diseases 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 208000008423 pleurisy Diseases 0.000 description 1
• 229920002492 poly(sulfone) Polymers 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 201000006292 polyarteritis nodosa Diseases 0.000 description 1
• 208000030428 polyarticular arthritis Diseases 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 208000005987 polymyositis Diseases 0.000 description 1
• 230000007824 polyneuropathy Effects 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 201000001474 proteinuria Diseases 0.000 description 1
• 208000029817 pulmonary adenocarcinoma in situ Diseases 0.000 description 1
• 208000005333 pulmonary edema Diseases 0.000 description 1
• 208000005069 pulmonary fibrosis Diseases 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 230000008521 reorganization Effects 0.000 description 1
• 201000004193 respiratory failure Diseases 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 201000003068 rheumatic fever Diseases 0.000 description 1
• 238000009666 routine test Methods 0.000 description 1
• 230000036185 rubor Effects 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 201000007416 salivary gland adenoid cystic carcinoma Diseases 0.000 description 1
• 201000000306 sarcoidosis Diseases 0.000 description 1
• 206010039667 schwannoma Diseases 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 229960003504 silicones Drugs 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 201000003708 skin melanoma Diseases 0.000 description 1
• 201000004477 skin sarcoma Diseases 0.000 description 1
• 208000000649 small cell carcinoma Diseases 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 201000002314 small intestine cancer Diseases 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 230000003595 spectral effect Effects 0.000 description 1
• 150000003408 sphingolipids Chemical class 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 208000021550 spleen neoplasm Diseases 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 238000011301 standard therapy Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 230000003068 static effect Effects 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 238000011476 stem cell transplantation Methods 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 208000008467 subacute bacterial endocarditis Diseases 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 238000000859 sublimation Methods 0.000 description 1
• 230000008022 sublimation Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 206010042863 synovial sarcoma Diseases 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 230000006794 tachycardia Effects 0.000 description 1
• BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
• 208000001644 thecoma Diseases 0.000 description 1
• 206010043554 thrombocytopenia Diseases 0.000 description 1
• 201000005060 thrombophlebitis Diseases 0.000 description 1
• 208000008732 thymoma Diseases 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 206010044412 transitional cell carcinoma Diseases 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 210000002993 trophoblast Anatomy 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 230000002476 tumorcidal effect Effects 0.000 description 1
• 238000002211 ultraviolet spectrum Methods 0.000 description 1
• 210000000626 ureter Anatomy 0.000 description 1
• 210000003708 urethra Anatomy 0.000 description 1
• 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 210000002229 urogenital system Anatomy 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 230000001457 vasomotor Effects 0.000 description 1
• 235000019871 vegetable fat Nutrition 0.000 description 1
• 201000010044 viral meningitis Diseases 0.000 description 1
• 210000003905 vulva Anatomy 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 239000011787 zinc oxide Substances 0.000 description 1
• 235000014692 zinc oxide Nutrition 0.000 description 1